The FDA issued approval to FCI Ophthalmics (Pembroke, MA) for the OphtaCath lacrimal duct balloon catheter, a device used to dilate the lacrimal duct for treatment of epiphora, or excessive tears in the eyes.
Available in 2mm or 3mm sizes, and a delivery device that uses one or two balloon catheters, the OphtaCath provides an incisionless and tube (Read more...)